tramadol has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutolo, M; Paolino, S; Pizzorni, C; Ruaro, B; Sulli, A | 1 |
| Alekperov, RT; Anikina, NV; Guseva, NG | 1 |
2 other study(ies) available for tramadol and Sclerosis, Systemic
| Article | Year |
|---|---|
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis.
Topics: Bosentan; Female; Fingers; Humans; Iloprost; Lasers; Methotrexate; Microcirculation; Microscopic Angioscopy; Middle Aged; para-Aminobenzoates; Raynaud Disease; Scattering, Radiation; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Tramadol; Treatment Outcome | 2017 |
[Tramadol in the vascular pains of patients with systemic scleroderma and other rheumatic diseases].
Topics: Adolescent; Adult; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Rheumatic Diseases; Scleroderma, Systemic; Tramadol; Vascular Diseases | 1994 |